Absci Corp (ABSI NASDAQ) stock market data APIs
$2.6815
-0.02(-0.7%)
as of July 14, 2025
Try our APIs with
free plan!
Absci Corp Financial Data Overview
Price chart is built with
Anychart
Absci Corporation operates as a data-first generative artificial intelligence (AI) drug creation company in the United States. The company combines AI with scalable wet lab technologies to design differentiated antibody therapeutics. Its preclinical development programs include ABS-101 for the treatment of inflammatory bowel disease; ABS-201 for treating androgenic alopecia; ABS-301 for the treatment of immuno-oncology; and ABS-501 for treating oncology. Absci Corporation has collaboration agreements with PrecisionLife, Memorial Sloan Kettering Cancer Center, Twist Bioscience, and Owkin for joint research and development activities. The company was founded in 2011 and is headquartered in Vancouver, Washington.
Prev. Close
2.6815
Open
2.6599
High
2.72
Low
2.6284
52 wk Range
2.01-6.33
Market Cap
339 M
Shares Outstanding
128 M
Revenue
4 815 K
EPS
-0.21
Beta
2.069
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Absci Corp data using free add-ons & libraries
Get Absci Corp Fundamental Data
Absci Corp Fundamental data includes:
- Net Revenue: 4 815 K
- EBITDA: -98 674 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: -0.2233
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Absci Corp News
New
Morgan Stanley Assumes Coverage on Absci Corporation (ABSI) with $7 Target
Absci Corporation (NASDAQ:ABSI) is among the fundamentally strong penny stocks to invest in. Morgan Stanley has assumed coverage on Absci Corporation (NASDAQ:ABSI) with an Overweight rating and a pric...
Absci appoints Mary Szela to board of directors and grants stock options
Absci Corp (NASDAQ:ABSI), a $339 million market cap biotechnology company trading at $2.65 per share, announced Monday the appointment of Mary Szela to its board of directors, effective the same day....
iRhythm Technologies Announces Board Member Retirements and New Director Appointments
SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, and prev...
iRhythm Technologies Announces Board Member Retirements and New Director Appointments
iRhythm SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- iRhythm Technologies, Inc. (NASDAQ:IRTC) , a leading digital health care company focused on creating trusted solutions that detect, predict, a...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
